Douglas JT - Search Results

1

Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, Reynolds P, Kropf DA, Carroll WR, Peters GE, Bucy RP, Curiel DT, Krasnykh V. Kasono K, et al. Among authors: douglas jt. Clin Cancer Res. 1999 Sep;5(9):2571-9. Clin Cancer Res. 1999. PMID: 10499635

2

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells.

Barnett BG, Tillman BW, Curiel DT, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Mol Ther. 2002 Sep;6(3):377-85. doi: 10.1006/mthe.2002.0670. Mol Ther. 2002. PMID: 12231174 Free article.

3

Targeted adenoviral vectors for cancer gene therapy (Review).

Douglas J, Curiel D. Douglas J, et al. Int J Oncol. 1997 Aug;11(2):341-8. doi: 10.3892/ijo.11.2.341. Int J Oncol. 1997. PMID: 21528220

4

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.

Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, Baird A, Campain JA, Curiel DT. Goldman CK, et al. Among authors: douglas jt. Cancer Res. 1997 Apr 15;57(8):1447-51. Cancer Res. 1997. PMID: 9108444

5

Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.

Douglas JT, Curiel DT. Douglas JT, et al. Neuromuscul Disord. 1997 Jul;7(5):284-98. doi: 10.1016/s0960-8966(97)00053-9. Neuromuscul Disord. 1997. PMID: 9267842 Review.

6

Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.

Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piché A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Rancourt C, et al. Among authors: douglas jt. Clin Cancer Res. 1998 Oct;4(10):2455-61. Clin Cancer Res. 1998. PMID: 9796978

7

Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.

Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. Miller CR, et al. Among authors: douglas jt. Cancer Res. 1998 Dec 15;58(24):5738-48. Cancer Res. 1998. PMID: 9865732

8

A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. Douglas JT, et al. Nat Biotechnol. 1999 May;17(5):470-5. doi: 10.1038/8647. Nat Biotechnol. 1999. PMID: 10331807

9

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.

Blackwell JL, Miller CR, Douglas JT, Li H, Reynolds PN, Carroll WR, Peters GE, Strong TV, Curiel DT. Blackwell JL, et al. Among authors: douglas jt. Arch Otolaryngol Head Neck Surg. 1999 Aug;125(8):856-63. doi: 10.1001/archotol.125.8.856. Arch Otolaryngol Head Neck Surg. 1999. PMID: 10448731

10

Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.

Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Tillman BW, et al. Among authors: douglas jt. Cancer Res. 2000 Oct 1;60(19):5456-63. Cancer Res. 2000. PMID: 11034088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters